{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T20:26:39Z","timestamp":1687465599959},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T00:00:00Z","timestamp":1287100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00467-010-1660-5","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T13:35:10Z","timestamp":1287063310000},"page":"111-117","source":"Crossref","is-referenced-by-count":5,"title":["Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function"],"prefix":"10.1007","volume":"26","author":[{"given":"Dagmar-Christiane","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Rahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Salewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Kundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert J.","family":"Behets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,15]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"1660_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","volume":"14","author":"SM Moe","year":"2007","unstructured":"Moe SM, Drueke T, Lameire N, Eknoyan G (2007) Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chron Kidney Dis 14:3\u201312","journal-title":"Adv Chron Kidney Dis"},{"key":"1660_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.semnephrol.2003.08.010","volume":"24","author":"KA Hruska","year":"2004","unstructured":"Hruska KA, Saab G, Chaudhary LR, Quinn CO, Lund RJ, Surendran K (2004) Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. Semin Nephrol 24:25\u201338","journal-title":"Semin Nephrol"},{"key":"1660_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2008.114","volume":"89","author":"PR Kiela","year":"2009","unstructured":"Kiela PR, Ghishan FK (2009) Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis. Lab Invest 89:7\u201314","journal-title":"Lab Invest"},{"key":"1660_CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","volume":"15","author":"RJ Lund","year":"2004","unstructured":"Lund RJ, Davies MR, Brown AJ, Hruska KA (2004) Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15:359\u2013369","journal-title":"J Am Soc Nephrol"},{"key":"1660_CR6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-006-0282-z","volume":"18","author":"LC Hofbauer","year":"2007","unstructured":"Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H (2007) Vascular calcification and osteoporosis\u2013from clinical observation towards molecular understanding. Osteoporos Int 18:251\u2013259","journal-title":"Osteoporos Int"},{"issue":"Suppl 4","key":"1660_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","volume":"9","author":"JR Green","year":"2004","unstructured":"Green JR (2004) Bisphosphonates: preclinical review. Oncologist 9[Suppl 4]:3\u201313","journal-title":"Oncologist"},{"key":"1660_CR8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032\u20131045","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"1660_CR9","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","volume":"119","author":"RG Russell","year":"2007","unstructured":"Russell RG (2007) Bisphosphonates: mode of action and pharmacology. Pediatrics 119[Suppl 2]:S150\u2013S162","journal-title":"Pediatrics"},{"key":"1660_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jphs.FPJ05019X","volume":"99","author":"K Tamura","year":"2005","unstructured":"Tamura K, Suzuki Y, Hashiba H, Tamura H, Aizawa S, Kogo H (2005) Effect of etidronate on aortic calcification and bone metabolism in calcitoriol-treated rats with subtotal nephrectomy. J Pharmacol Sci 99:89\u201394","journal-title":"J Pharmacol Sci"},{"key":"1660_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2008.646","volume":"75","author":"KA Lomashvili","year":"2009","unstructured":"Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC (2009) Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 75:617\u2013625","journal-title":"Kidney Int"},{"key":"1660_CR12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ki.2008.663","volume":"75","author":"EG Neven","year":"2009","unstructured":"Neven EG, De Broe ME, D'Haese PC (2009) Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Kidney Int 75:580\u2013582","journal-title":"Kidney Int"},{"key":"1660_CR13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","volume":"21","author":"PA Price","year":"2001","unstructured":"Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817\u2013824","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1660_CR14","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1093\/jn\/131.11.2910","volume":"131","author":"PA Price","year":"2001","unstructured":"Price PA, Buckley JR, Williamson MK (2001) The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131:2910\u20132915","journal-title":"J Nutr"},{"key":"1660_CR15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.ki.5001841","volume":"70","author":"PA Price","year":"2006","unstructured":"Price PA, Roublick AM, Williamson MK (2006) Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 70:1577\u20131583","journal-title":"Kidney Int"},{"key":"1660_CR16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.ki.5001899","volume":"70","author":"V Persy","year":"2006","unstructured":"Persy V, De Broe M, Ketteler M (2006) Bisphosphonates prevent experimental vascular calcification: treat the bone to cure the vessels? Kidney Int 70:1537\u20131538","journal-title":"Kidney Int"},{"key":"1660_CR17","first-page":"45","volume":"54","author":"Z Geng","year":"2000","unstructured":"Geng Z, Monier-Faugere MC, Bauss F, Malluche HH (2000) Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure. Clin Nephrol 54:45\u201353","journal-title":"Clin Nephrol"},{"key":"1660_CR18","first-page":"174","volume":"5","author":"A Tomat","year":"2005","unstructured":"Tomat A, Gamba CA, Mandalunis P, De Grandi MC, Somoza J, Friedman S, Zeni S (2005) Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease. J Musculoskelet Neuronal Interact 5:174\u2013181","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1660_CR19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","volume":"23","author":"D Haffner","year":"2005","unstructured":"Haffner D, Hocher B, M\u00fcller D, Simon K, Konig K, Richter CM, Eggert B, Schwarz J, Godes M, Nissel R, Querfeld U (2005) Systemic cardiovascular disease in uremic rats induced by 1, 25(OH)2D3. J Hypertens 23:1067\u20131075","journal-title":"J Hypertens"},{"key":"1660_CR20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/01.ju.0000104561.90514.cb","volume":"171","author":"D Brkovic","year":"2004","unstructured":"Brkovic D, Seibel M, Juchem R, Linke J, Rohde D, Bauss F (2004) Effect of augmentation cystoplasty on bone metabolism in chronic uremic rats. J Urol 171:921\u2013925","journal-title":"J Urol"},{"key":"1660_CR21","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1464-410X.2005.05468.x","volume":"95","author":"D Brkovic","year":"2005","unstructured":"Brkovic D, Linke J, Jakse G, Bauss F (2005) Changes in bone structure after augmentation cystoplasty in chronic uraemic rats. BJU Int 95:1066\u20131070","journal-title":"BJU Int"},{"key":"1660_CR22","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1523-1755.2005.00281.x","volume":"67","author":"GJ Behets","year":"2005","unstructured":"Behets GJ, Verberckmoes SC, Oste L, Bervoets AR, Salome M, Cox AG, Denton J, De Broe ME, D'Haese PC (2005) Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate. Kidney Int 67:1830\u20131836","journal-title":"Kidney Int"},{"key":"1660_CR23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0714.1982.tb00172.x","volume":"11","author":"K Donath","year":"1982","unstructured":"Donath K, Breuner G (1982) A method for the study of undecalcified bones and teeth with attached soft tissues. The S\u00e4ge-Schliff (sawing and grinding) technique. J Oral Pathol 11:318\u2013326","journal-title":"J Oral Pathol"},{"key":"1660_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"1660_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jemt.1070280606","volume":"28","author":"EB Hunziker","year":"1994","unstructured":"Hunziker EB (1994) Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech 28:505\u2013519","journal-title":"Microsc Res Tech"},{"key":"1660_CR26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/his.1994.17.4.357","volume":"17","author":"JA Eurell","year":"1994","unstructured":"Eurell JA, Sterchi DL (1994) Microwaveable toluidine blue stain for surface staining of undecalcified bone sections. J Histotechnol 17:357\u2013359","journal-title":"J Histotechnol"},{"key":"1660_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2818.1986.tb02765.x","volume":"143","author":"LM Cruz-Orive","year":"1986","unstructured":"Cruz-Orive LM, Hunziker EB (1986) Stereology for anisotropic cells: application to growth cartilage. J Microsc 143:47\u201380","journal-title":"J Microsc"},{"key":"1660_CR28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1681\/ASN.V105971","volume":"10","author":"A Cobo","year":"1999","unstructured":"Cobo A, Lopez JM, Carbajo E, Santos F, Alvarez J, Fernandez M, Weruaga A (1999) Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10:971\u2013979","journal-title":"J Am Soc Nephrol"},{"key":"1660_CR29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"1660_CR30","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"1660_CR31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1600-6143.2005.00914.x","volume":"5","author":"MB Ishitani","year":"2005","unstructured":"Ishitani MB, Milliner DS, Kim DY, Bohorquez HE, Heimbach JK, Sheedy PF 2nd, Morgenstern BZ, Gloor JM, Murphy JG, McBane RD, Bielak LF, Peyser PA, Stegall MD (2005) Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant 5:1689\u20131693","journal-title":"Am J Transplant"},{"key":"1660_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpcardio0725","volume":"4","author":"P Raggi","year":"2007","unstructured":"Raggi P, Giachelli C, Bellasi A (2007) Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med 4:26\u201333","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"1660_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2215\/CJN.02550508","volume":"4","author":"ND Toussaint","year":"2009","unstructured":"Toussaint ND, Elder GJ, Kerr PG (2009) Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol 4:221\u2013233","journal-title":"Clin J Am Soc Nephrol"},{"key":"1660_CR34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00223-002-1006-9","volume":"71","author":"PA Price","year":"2002","unstructured":"Price PA, Omid N, Than TN, Williamson MK (2002) The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption. Calcif Tissue Int 71:356\u2013363","journal-title":"Calcif Tissue Int"},{"key":"1660_CR35","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","volume":"21","author":"S Briese","year":"2006","unstructured":"Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease\u2013impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906\u20131914","journal-title":"Nephrol Dial Transplant"},{"key":"1660_CR36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"343","author":"D Haffner","year":"2000","unstructured":"Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German study group for growth hormone treatment in chronic renal failure. N Engl J Med 343:923\u2013930","journal-title":"N Engl J Med"},{"key":"1660_CR37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00467-004-1713-8","volume":"20","author":"R Rabkin","year":"2005","unstructured":"Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK\/STAT signaling. Pediatr Nephrol 20:313\u2013318","journal-title":"Pediatr Nephrol"},{"key":"1660_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"GH Nancollas","year":"2006","unstructured":"Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617\u2013627","journal-title":"Bone"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-010-1660-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1660-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T21:26:28Z","timestamp":1636665988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-010-1660-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1007\/s00467-010-1660-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,15]]}}}